Hypogonadism Recruiting Phase 4 Trials for Anastrozole (DB01217)

IndicationStatusPhase
DBCOND0009256 (Hypogonadism)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02959853Aromatase Inhibitors and Weight Loss in Severely Obese Hypogonadal Male Veterans (Pilot)Treatment